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Abstract
Cystic ﬁbrosis (CF) is a multisystemic, autosomal recessive disorder that predominantly affects infants, children, and young
adults. Manifestations of CF involve the lung and gastrointestinal tract, including the pancreas. Pancreatic cystosis is a rare
condition typically seen in CF during the second decade of life. It has characteristic magnetic resonance imaging (MRI) and
ultrasound (US) features. A large cystic mass replacing the pancreas has been found by US and MRI study carried out as a
part of clinical workup for a 17-year-old girl, known to have CF and presented with epigastric pain and a palpable mass.
There was no history of trauma or clinical evidence of pancreatitis. On the basis of MRI ﬁndings and the patient age, a
radiological diagnosis of pancreatic cystosis is securely made. Biopsy should be preserved for those who have atypical
presentation.
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Introduction
Pancreatic cystosis is extremely rare, and to our knowl-
edge, only a few cases have been reported in the literature.[1]
It is typically seen in the second decade of life and described
as complete replacement of the pancreas by cysts of different
sizes, ranging from 1 to 12 cm, and lack of normal pancreatic
tissue identiﬁcation.[2]
Case Report
A 17-year-old girl, known to have cystic ﬁbrosis, presented
to the emergency department with recurrent epigastric pain
and a palpable mass. The pain was diffuse and continuous,
without exacerbating or relieving factors. Medical history was
signiﬁcant for cystic ﬁbrosis, pancreatic insufﬁciency, and
pulmonary disease. Surgical history showed no abdominal
surgeries. Medications included pancreatic enzyme supple-
ments, proton-pump inhibitors, b-agonist, fat-soluble vitamin
supplements, dornase alpha, and inhaled tobramycin. Physical
examination showed diffuse abdominal tenderness to light
palpation and a large left hypochondrial mass. Pulmonary
examination showed poor respiratory effort but clear breath
sounds. There was no clinical or biochemical evidence of
pancreatitis. A bedside ultrasound was performed [Figure 1],
which showed a large septated cystic mass occupying the
expected location of the pancreas. There was no solid
component or signiﬁcant vascularity. The pancreatic duct
was not clearly visualized. The liver, common bile duct,
spleen, and the kidneys were normal. The CT scan was
withheld to avoid radiation.




Figure 1: Doppler ultrasound of the abdomen shows multiseptated
cystic mass with internal echogenicity. There is mild vascularity in the
septations.
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Case Report
An abdominal magnetic resonance imaging (MRI)
[Figure 2] showed multiple innumerable cysts, ranging from
1 to 18 cm, replacing the pancreas. Most of the cysts were
hypointense in T1 sequence, and almost all of them were
T2 hyperintense. Some of the cysts were T1 hyperintense,
considered as high protein content. There were multiple ﬂuid/
ﬂuid levels, likely related to prior hemorrhagic episodes. There
were a few enhancing septations and no solid component. No
normal pancreatic tissue was appreciated. A radiological
diagnosis of pancreatic cystosis was performed based on
the typical MRI and ultrasound features.
Discussion
Cystic ﬁbrosis is the most lethal autosomal recessive
disease among Caucasian people, with approximately inci-
dence of 1/2500 live birth.[1,3] The pancreas is involved in
approximately 85% of patients with cystic ﬁbrosis at some time
in their lives.[4] The clinical symptoms, including steatorrhea,
fat intolerance, abdominal pain, and failure to thrive, will be
shown after 90% loss of pancreatic tissue.
Four imaging manifestation of the pancreatic involvement
have been discussed in the literature[1]: (1) partial ﬁbro-fatty
replacement of the pancreatic tissue, which is most common in
the tail as compared to the body; (2) complete ﬁbro-fatty
replacement; (3) atrophy without ﬁbro-fatty replacement; and
(4) pancreatic cystosis.
The partial and complete ﬁbro-fatty replacement, and the
atrophy represent 16%, 42%, and 24% of the cases, respec-
tively.[5] They can be associated with micro- or macrocysts.
Pancreatic cystosis is extremely rare. It is typically seen in
the second decade of life and described as complete
replacement of the pancreas by cysts of different sizes,
ranging from 1 to 12 cm, and lack of normal pancreatic tissue
identiﬁcation. The main etiology has been thought to be
(c) (d) (e)
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Figure 2: An abdominal MRI. (a) Axial T2 fat saturated obtained at the level of the pancreases and (b) coronal T2 shows a large multiseptated
hyperintense cystic mass (*) in the left hypochondrium. (c) Magnetic resonance cholangiopancreatography (MRCP) shows multiple smaller cysts
(empty arrows) replacing the body and the head of the pancreas. (d) Axial T1 fat saturated and (e) enhanced axial T1 show homogenous hypointensity
of the mass (*) and enhancement of the septations (solid arrows). The liver (L), kidneys (K), spleen (S), and the duodenum (D) are normal.
International Journal of Medical Science and Public Health | 2015 | Vol 4 | Issue 2 308
Mohammad A Wazzan: Pancreatic cystosis in cystic ﬁbrosis
related to a defect in bicarbonate transport,[6] which will lead to
diluted protein and subsequent ductal ectasia.
The top differential diagnosis for pancreatic cystic lesion
would include the following:
 Pancreatic psudocyst, which usually is less numerous and
associated with inﬂammatory process or trauma.[7]
 Mucinous and serous cystic diseases that typically involve
middle-aged and older women.
 Intraductal papillary mucinous tumor typically shows
communication with the pancreatic duct.
 Pancreatic involvement in polycystic kidneys disease,
which can be excluded if the kidneys are normal.
 Von Hippel–Lindau disease, which is also excluded in the
sitting of normal kidneys.
On the basis of MRI ﬁndings and the patient age, those
differential diagnoses were excluded and a diagnosis of
pancreatic cystosis was made. Biopsy has been deemed
unnecessary in patent with pancreatic cystosis.[1]
Conclusion
Conclusively, in case of macrocystic replacement of the
pancreas seen in a patient with cystic ﬁbrosis, an imaging-
based diagnosis of pancreatic cystosis should be made.
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